Baird analyst Michael Ulz is Incrementally positive on Tesaro (NASDAQ: TSRO) niraparib NDA acceptance with no AdCom expected.Ulz commented, "Tesaro ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE